Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2013 08:16 ET | Source: ALK Abello

ALK: FDA offentliggør briefingdokumenter forud for mødet i den rådgivende komite om tabletvaccinen mod græspollenallergi

København, 2013-12-10 14:16 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddelte i dag, at de amerikanske sundhedsmyndigheder (FDA) har offentliggjort...
December 10, 2013 08:16 ET | Source: ALK Abello

ALK announces posting of briefing documents for FDA Advisory Committee meeting on the grass sublingual AIT tablet

Copenhagen, 2013-12-10 14:16 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the US Food and Drug Administration (FDA) has posted briefing documents...
November 09, 2013 12:36 ET | Source: ALK Abello

ALKs partner i Nordamerika, Merck, rapporterer fase III-resultater med den tabletbaserede vaccine mod græspollenallergi

København, 2013-11-09 18:36 CET (GLOBE NEWSWIRE) -- ALKs (ALKB:DC / OMX:ALK B / AKABY / AKBLF) partner i Nordamerika, Merck (NYSE: MRK) meddeler, at resultater fra et pivotalt fase...
November 09, 2013 12:36 ET | Source: ALK Abello

ALK's partner in North America, Merck, reports Phase III data on investigational grass sublingual allergy immunotherapy tablet

Copenhagen, 2013-11-09 18:36 CET (GLOBE NEWSWIRE) -- ALK's (ALKB:DC / OMX: ALK B / AKABY / AKBLF) partner for North America, Merck (NYSE: MRK) reported that data from a pivotal Phase III...
November 08, 2013 02:22 ET | Source: ALK Abello

Nine-month interim report (Q3) 2013

Copenhagen, 2013-11-08 08:22 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX:ALK B / AKABY / AKBLF) (unaudited) Performance for the period (Comparative figures for 2012 are shown in brackets...
November 08, 2013 02:22 ET | Source: ALK Abello

Delårsrapport 9 måneder (Q3) 2013

København, 2013-11-08 08:22 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX:ALK B / AKABY / AKBLF) (urevideret) Resultater for perioden (Sammenligningstal for samme periode sidste år er...
November 01, 2013 08:42 ET | Source: ALK Abello

Release date of nine-month interim report (Q3) 2013 for ALK

Copenhagen, 2013-11-01 13:42 CET (GLOBE NEWSWIRE) -- On Friday 8 November 2013, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its interim report for the nine months ended 30 September...
November 01, 2013 08:42 ET | Source: ALK Abello

Dato for offentliggørelse af delårsrapport for 9 måneder (Q3) 2013 for ALK

København, 2013-11-01 13:42 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør fredag den 8. november 2013 delårsrapport for 9 måneder (Q3) 2013. ALK...
October 30, 2013 07:51 ET | Source: ALK Abello

ALK to present at two upcoming 2013 Investor Conferences

Copenhagen, 2013-10-30 12:51 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the Company will present at the Credit Suisse 2013 Healthcare Conference...
October 23, 2013 02:45 ET | Source: ALK Abello

FDA reschedules Advisory Committee meeting for grass AIT tablet

Copenhagen, 2013-10-23 08:45 CEST (GLOBE NEWSWIRE) -- ALK (ALK-B.CO / OMX: ALK B / AKABY / AKBLF) today announced that the US Food and Drug Administration (FDA) has rescheduled the...